DK138691B - Analogous process for the preparation of imidazo (5,1-f) triazinones or their salts. - Google Patents

Analogous process for the preparation of imidazo (5,1-f) triazinones or their salts.

Info

Publication number
DK138691B
DK138691B DK525172AA DK525172A DK138691B DK 138691 B DK138691 B DK 138691B DK 525172A A DK525172A A DK 525172AA DK 525172 A DK525172 A DK 525172A DK 138691 B DK138691 B DK 138691B
Authority
DK
Denmark
Prior art keywords
triazinones
imidazo
salts
preparation
analogous process
Prior art date
Application number
DK525172AA
Other languages
Danish (da)
Other versions
DK138691C (en
Inventor
Susan Constance Garside
David Hartley
Lawrence Henry Charles Lunts
Alexander William Oxford
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of DK138691B publication Critical patent/DK138691B/en
Application granted granted Critical
Publication of DK138691C publication Critical patent/DK138691C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK525172AA 1971-11-19 1972-10-23 Analogous process for the preparation of imidazo (5,1-f) triazinones or their salts. DK138691B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5375071A GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions

Publications (2)

Publication Number Publication Date
DK138691B true DK138691B (en) 1978-10-16
DK138691C DK138691C (en) 1979-03-26

Family

ID=10468856

Family Applications (1)

Application Number Title Priority Date Filing Date
DK525172AA DK138691B (en) 1971-11-19 1972-10-23 Analogous process for the preparation of imidazo (5,1-f) triazinones or their salts.

Country Status (18)

Country Link
US (1) US3840537A (en)
JP (1) JPS563873B2 (en)
AT (1) AT321923B (en)
AU (1) AU472127B2 (en)
BE (1) BE791025A (en)
CA (1) CA990292A (en)
CH (1) CH594671A5 (en)
DE (1) DE2255172A1 (en)
DK (1) DK138691B (en)
ES (1) ES408736A1 (en)
FR (1) FR2160407B1 (en)
GB (1) GB1400999A (en)
IE (1) IE37046B1 (en)
IL (1) IL40686A (en)
NL (1) NL7215646A (en)
PH (1) PH9669A (en)
SE (1) SE402915B (en)
ZA (1) ZA727532B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457873A (en) * 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DE2314488C3 (en) * 1973-03-23 1979-01-04 C.H. Boehringer Sohn, 6507 Ingelheim 8- (2,6-Dichlorophenyl) -7- (4-chlorophenyl) -5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazine, process for its preparation and medicament containing it
DE2335193A1 (en) * 1973-07-11 1975-01-30 Hoechst Ag BIS-TRIAZINOBENZIMIDAZOLE AND THEIR PRODUCTION
US4107307A (en) * 1977-02-03 1978-08-15 American Cyanamid Company Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
USRE30511E (en) * 1977-02-03 1981-02-10 American Cyanamid Company Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
US4115572A (en) * 1977-02-03 1978-09-19 American Cyanamid Company Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma
DK109578A (en) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd PROCEDURE FOR MAKING HETEROCYCLIC COMPOUNDS
US4107308A (en) * 1977-10-18 1978-08-15 American Cyanamid Company Imidazo[1,5-d]-as-triazines
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
HU187474B (en) * 1981-11-18 1986-01-28 Gyogyszerkutato Intezet,Hu Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives
US4395547A (en) * 1982-02-10 1983-07-26 American Cyanamid Co. Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
GB2346877B (en) * 1997-11-12 2001-12-05 Bayer Ag 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
DE19827640A1 (en) * 1998-06-20 1999-12-23 Bayer Ag New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction
NZ527232A (en) 1998-08-26 2005-03-24 Smithkline Beecham Corp A composition contaning a PDE 4 inhibitor and a beta adrenergic bronchodilator useful for treating pulmonary diseases
EP2193808A1 (en) * 1999-08-21 2010-06-09 Nycomed GmbH Synergistic combination
JP4540295B2 (en) * 2001-05-09 2010-09-08 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト New uses for 2-phenyl substituted imidazotriazinones
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
GB0113344D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
DE10135815A1 (en) 2001-07-23 2003-02-06 Bayer Ag Use of imidazo-triazinone derivative phosphodiesterase 5 inhibitors e.g. for treatment of cardiac insufficiency, psoriasis, diabetes, cancer, glaucoma, bladder disease, Parkinson's disease or pain
DE10232113A1 (en) 2002-07-16 2004-01-29 Bayer Ag Medicinal products containing vardenafil hydrochloride trihydrate
DE602004021363D1 (en) * 2003-04-01 2009-07-16 Smithkline Beecham Corp IMIDAZOTRIAZIN COMPOUNDS FOR THE TREATMENT OF CANCER DISEASES
JP4832426B2 (en) 2004-04-02 2011-12-07 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド 6,6-bicyclic substituted heterobicyclic protein kinase inhibitors
DE102005001989A1 (en) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenous formulations of PDE inhibitors
DE102005009241A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with controlled bioavailability
DE102005009240A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with improved pharmacokinetic properties
BRPI0616633A2 (en) * 2005-09-29 2011-06-28 Bayer Healthcare Ag pde inhibitors and combinations thereof for the treatment of urological disorders
BRPI0618622A2 (en) 2005-11-17 2011-09-06 Osi Pharm Inc compound, composition, and use of a compound
US20100184769A1 (en) * 2007-06-13 2010-07-22 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
CN102405214A (en) 2009-04-20 2012-04-04 Osi药物有限责任公司 Preparation of c-pyrazine-methylamines
CN103374002B (en) * 2012-04-19 2015-07-15 山东轩竹医药科技有限公司 Phosphodiesterase-5 inhibitor
WO2016147659A1 (en) * 2015-03-16 2016-09-22 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic imidazolo derivative
WO2017000276A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
WO2017204316A1 (en) * 2016-05-27 2017-11-30 塩野義製薬株式会社 5-oxo-1,2,4-triazine derivative, and pharmaceutical composition thereof

Also Published As

Publication number Publication date
CA990292A (en) 1976-06-01
PH9669A (en) 1976-02-10
FR2160407A1 (en) 1973-06-29
FR2160407B1 (en) 1975-10-17
JPS4857993A (en) 1973-08-14
IL40686A0 (en) 1972-12-29
DK138691C (en) 1979-03-26
SE402915B (en) 1978-07-24
IE37046L (en) 1973-05-19
AT321923B (en) 1975-04-25
IE37046B1 (en) 1977-04-27
GB1400999A (en) 1975-07-16
AU4819172A (en) 1974-05-16
AU472127B2 (en) 1976-05-20
ES408736A1 (en) 1976-03-01
ZA727532B (en) 1973-07-25
IL40686A (en) 1975-12-31
DE2255172A1 (en) 1973-05-24
US3840537A (en) 1974-10-08
BE791025A (en) 1973-05-07
JPS563873B2 (en) 1981-01-27
CH594671A5 (en) 1978-01-13
NL7215646A (en) 1973-05-22

Similar Documents

Publication Publication Date Title
DK138691B (en) Analogous process for the preparation of imidazo (5,1-f) triazinones or their salts.
DK131725B (en) Analogous process for the preparation of 2,4-diaminoquinazolines or salts thereof.
DK134113B (en) Analogous process for the preparation of 1,2,3,4-tetrahydro-7-halogen or 7-trifluoromethyl-6-sulfamyl-4-quinazolinones or salts thereof.
DK132172B (en) Analogous process for the preparation of 6,7-benzomorphans or their salts.
DK138692B (en) Analogous process for the preparation of s-triazolo (4,3-b) pyridazines or salts thereof.
DK126788B (en) Analogous process for the preparation of γ-morpholino-p-amino-butyrophenones or salts thereof.
DK136060B (en) Analogous process for the preparation of 3-substituted 1,4,5,6-tetrahydropyridines or salts thereof.
DK129650B (en) Analogous process for the preparation of 1-phenoxy-2-hydroxy-3-amino-propanes or salts thereof.
DK138854B (en) Analogous process for the preparation of s-triazolo (4,3-a) (1,4) benzodiazepine derivatives or 5-oxides or salts thereof.
DK128078B (en) Analogous process for the preparation of 1,2,3,4-tetrahydroisoquinoline derivatives or salts thereof.
DK140545B (en) Analogous process for the preparation of benzoylphenylbutyric acid derivatives or their salts.
DK138020B (en) Analogous process for the preparation of pyrazolodiazepine compounds or salts thereof.
DK140761B (en) Process for the preparation of indolo (2,3-a) quinolizines or salts thereof.
DK135534B (en) Process for the preparation of pyrasol- (3,4-d) -pyrimidines or salts thereof.
DK139388B (en) Process for the preparation of 2-amino-4-hydroxy-7,7-dimethyl-7,8-dihydropteridines or tautomers thereof or salts of these compounds.
DK130978B (en) Analogous process for the preparation of 2-methylamino-4'-methyl-4-piperazinyl-6-chloro-5-methylthiopyrimidine or salts thereof.
DK138797B (en) Analogous process for the preparation of 1,4-benzodiazepine derivatives or N-oxides or salts thereof.
DK133979B (en) Analogous process for the preparation of 5-methyl-10- (beta-alkylaminethyl) -dibenzo (b, f) -azepines or salts thereof.
DK125025B (en) Analogous process for the preparation of 2,1,3-benzothiadiazole compounds or salts thereof.
DK135504B (en) Analogous process for the preparation of 6-substituted 3-carbethoxyhydrazinopyridazines or salts thereof.
DK112944B (en) Process for the preparation of 7- (2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl) -cephalosporanic acid or salts thereof.
DK131374B (en) Process for the preparation of 1,4-benzodiazepine derivatives or salts thereof.
DK136906B (en) Analogous process for the preparation of dibenzoxyrenazepine derivatives or salts thereof.
DK133622B (en) Process for the preparation of antibiotic A28695A or A28695B or salts thereof.
DK139943B (en) Process for the preparation of triazolo (4,3a) (1,4) benzodiazepine-5N-oxide derivatives or acid addition salts thereof.